Publications by authors named "C Bradaric"
Background: Older patients are often underrepresented in clinical trials investigating the treatment of coronary drug-eluting stent (DES) restenosis, but outcome data is urgently needed in an ageing society. Thus, the aim of this observational, retrospective study was to close this lack of evidence.
Methods: Between January 2007 and February 2021, 3511 patients with 5497 in-stent restenosis (ISR) lesions were treated at two large-volume centers in Munich, Germany.
Sex-related outcomes after percutaneous coronary intervention of in-stent restenosis.
Cardiovasc Interv Ther
February 2025
Limited data are available for sex-related long-term outcomes of patients treated for coronary drug-eluting stent (DES) restenosis. The aim of this observational, retrospective analysis was to close this lack of evidence. Between January 2007 and February 2021, a total of 3511 patients with 5497 in-stent restenosis (ISR) lesions were treated at two large-volume centers in Munich, Germany, of which 763 (21.
View Article and Find Full Text PDFArticle Synopsis
- Aortic stenosis (AS) leads to different patterns of left ventricular (LV) hypertrophy in patients, impacting their clinical outcomes after undergoing transcatheter aortic valve replacement (TAVR).
- A study involving 1,703 patients categorized them based on their LV mass and wall thickness, revealing that those with eccentric hypertrophy (EH) experienced significantly higher mortality rates within one and five years post-procedure compared to other groups.
- Additionally, genetic factors measured by polygenic risk scores (PRS) may help predict the development of hypertrophy patterns and could provide insights into future treatment options for patients with AS.
The performance of an everolimus-eluting bioresorbable scaffold (BRS) was inferior to an everolimus-eluting metallic drug-eluting stent (DES) with permanent polymer, mainly due the mechanical features of BRS technology. The performance of BRS as compared to metallic DES with bioresorbable polymers remains unstudied. This prospective, randomized, multicenter, clinical trial enrolled patients who underwent coronary stenting for de novo coronary lesions.
View Article and Find Full Text PDFBackground: Simultaneous positron emission tomography (PET) and magnetic resonance imaging (MRI) is a novel hybrid imaging method integrating the advances of morphological tissue characterization of MRI with the pathophysiological insights of PET applications.
Aim: This study evaluated the use of simultaneous 18-FDG PET/MR imaging for characterizing atherosclerotic lesions in lower extremity arterial disease (LEAD).
Methods: Eight patients with symptomatic stenoses of the superficial femoral artery (SFA) under simultaneous acquisition of 18-FDG PET and contrast-enhanced MRI using an integrated whole-body PET/MRI scanner.